lobbying_activities: 1376190
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1376190 | 6f1f18de-64d6-4851-82f0-4da018a62f47 | Q1 | LIFE TECHNOLOGIES CORPORATION | 400391833 | LIFE TECHNOLOGIES CORPORATION | 2013 | first_quarter | MED | Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. No bill numbers to date: BETTER Care Act/Modernizing Laboratory Test Standards for Patients Act of 2011/Medical Testing Availability Act; Provisions regarding lab developed tests. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2013-04-18T09:08:50.193000-04:00 |